文献速递心脑血管急症重症综合管理与镇静镇痛

使用食管冷却装置进行心脏骤停后目标温度管理(COOL研究):可行性与安全性研究

Targeted temperature management using the "Esophageal Cooling Device" after cardiac arrest (the COOL study): A feasibility and safety study.
PubMed 文献 · Resuscitation · 2017-09-23
一句话结论在院外心脏骤停昏迷患者中,单用食管冷却装置实施33°C目标温度管理似乎可行、安全且精准,尤其在维持阶段。

该单中心、前瞻性、干预性研究纳入17例院外心脏骤停昏迷患者,排除心脏骤停至自主循环恢复>60分钟、持续自主循环恢复至纳入>360分钟及已知食管疾病者。使用食管冷却装置连接热交换器控制台,不使用冷液体,实施32–34°C目标温度管理。主要终点为单用该装置诱导、维持和复温的可行性;次要终点为不良事件,重点关注消化系统损伤。结果显示降温速率0.26°C/h,所有患者达到32–34°C范围,维持阶段温度偏差0.10°C,偏差>1°C的时间为0小时,复温速率0.20°C/h;16次胃镜检查中10次正常,轻微食管胃损伤与常规口胃管损伤相似,1例严重食管炎非冷却相关,3个月随访存活者无胃肠道主诉。作者认为该装置似乎是安全、精准的半侵入性冷却方法。

要点

  • 17例院外心脏骤停昏迷患者单用食管冷却装置实施33°C目标温度管理,降温速率0.26°C/h(四分位距0.19–0.36),3例未达到33°C。
  • 所有患者达到32–34°C范围,范围内时间26小时(四分位距21–28),维持阶段温度偏差0.10°C(四分位距0.03–0.20),偏差>1°C的时间为0小时。
  • 复温速率0.20°C/h(四分位距0.18–0.22)。
  • 16次胃镜检查中10次(62.5%)正常,轻微食管胃损伤发生率分别为37.5%和19%,与常规口胃管损伤相似;1例严重食管炎非冷却相关。
  • 3个月随访时9例存活者均无胃肠道主诉。

适用人群与场景

  • 院外心脏骤停后昏迷患者,纳入17例。
  • 排除标准:心脏骤停至自主循环恢复时间>60分钟、持续自主循环恢复至纳入时间>360分钟、已知食管疾病。

诊断标准与关键阈值

  • 目标温度管理范围32–34°C,目标温度33°C。

处置流程与药物剂量

  • 使用食管冷却装置(Advanced Cooling Therapy,美国)连接热交换器控制台(Meditherm III®,Gaymar,法国),不使用冷液体,实施32–34°C目标温度管理。
  • 降温至目标温度33°C,降温速率0.26°C/h(四分位距0.19–0.36)。
  • 维持阶段温度偏差0.10°C(四分位距0.03–0.20),偏差>1°C的时间为0小时。
  • 复温速率0.20°C/h(四分位距0.18–0.22)。

研究设计与关键结果

  • 单中心、前瞻性、干预性研究,纳入17例院外心脏骤停昏迷患者,单用食管冷却装置实施32–34°C目标温度管理。
  • 主要终点可行性:所有患者达到32–34°C范围,范围内时间26小时(四分位距21–28),3例未达到33°C;降温速率0.26°C/h(四分位距0.19–0.36),复温速率0.20°C/h(四分位距0.18–0.22)。
  • 次要终点不良事件:16次胃镜检查中10次(62.5%)正常,轻微食管胃损伤发生率分别为37.5%和19%,与常规口胃管损伤相似;1例严重食管炎模仿消化性溃疡病变,非冷却相关。
  • 3个月随访时9例存活者均无胃肠道主诉。

证据类型、等级与局限

  • 证据类型:单中心、前瞻性、干预性可行性及安全性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为食管冷却装置似乎是安全、精准的半侵入性冷却方法,尤其适用于维持阶段,可用于院外心脏骤停后接受33°C目标温度管理的患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Targeted temperature management (TTM) between 32 and 36°C is recommended after out-of-hospital cardiac arrest (OHCA). We aimed to assess the feasibility and safety of the "Esophageal Cooling Device" (ECD) in performing TTM.

PATIENTS AND METHODS: This single-centre, prospective, interventional study included 17 comatose OHCA patients. Main exclusion criteria were: delay between OHCA and return of spontaneous circulation (ROSC)>60min, delay between sustained ROSC and inclusion >360min, known oesophageal disease. A TTM between 32 and 34°C was performed using the ECD (Advanced Cooling Therapy, USA) connected to a heat exchanger console (Meditherm III®, Gaymar, France), without cold fluids' use. Primary endpoint was feasibility of inducing, maintaining TTM, and rewarming using the ECD alone. Secondary endpoints were adverse events, focusing on potential digestive damages. Results were expressed as median (interquartiles 25-75).

RESULTS: Cooling rate to reach the Target Temperature (33°C-TT) was 0.26°C/h [0.19-0.36]. All patients reached the 32-34°C range with a time spent within the range of 26h [21-28] (3 patients did not reach 33°C). Temperature deviation outside the TT during TTM-maintenance was 0.10°C [0.03-0.20]. Time with deviation >1°C was 0h. Rewarming rate was 0.20°C/h [0.18-0.22]. Among the 16 gastrointestinal endoscopy procedures performed, 10 (62.5%) were normal. Minor oeso-gastric injuries (37.5% and 19%, respectively) were similar to usual orogastric tube injuries. One patient experienced severe oesophagitis mimicking peptic lesions, not cooling-related. No patient among the 9 alive at 3-month follow-up had gastrointestinal complains.

CONCLUSION: ECD seems an interesting, safe, accurate, semi-invasive cooling method in OHCA patients treated with 33°C-TTM, particularly during the maintenance phase.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Goury A, Poirson F, Chaput U, et al. Targeted temperature management using the "Esophageal Cooling Device" after cardiac arrest (the COOL study): A feasibility and safety study. Resuscitation. 2017. PMID: 28951293. doi:10.1016/j.resuscitation.2017.09.021

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。